AMS Equity Snapshot
VVY Weekly Equity Report
Vivoryon Therapeutics N.V.
What the company does
Vivoryon Therapeutics N.V. operates as a clinical stage biopharmaceutical company that focuses on research, development, and commercialize small molecule-based medicines. Its pipeline products target toxic pyroglutamate-Abeta (pGlu-Abeta), which inhibits the production of pGlu-Abeta. The company's lead product candidate is PQ912, a nanomolar QPCT inhibitor that has completed Phase IIb clinical trials for use in the treatment of Alzheimer's disease. In addition, the company is developing a monoclonal antibody PBD-C06 is for N3pE-Abeta. Vivoryon Therapeutics N.V. has a collaboration agreement with Nordic Bioscience for the clinical development of PQ912 for Alzheimer's disease; and research collaboration with …
What the weekly tape is saying
VVY closed the latest completed week at 1.15 EUR. The 4-week return is -8.4% and the 12-week return is -10.9%. Trend Signal is inactive, Market Dynamics is -0.46. Setup signature: Risk-first tape with a 24/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 1.40 EUR
- Vs Trend Line
- -17.6%
- Fair Value
- 3.62 EUR
- Vs Fair Value
- -68.2%
- 52W High
- 1.84 EUR
- 52W Low
- 1.10 EUR
- Drawdown
- -37.5%
- Range Position
- 6.8%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 2
- 52W Active Breadth
- 3.8%
- Sector Scope
- NL Healthcare
- Sector Rank
- 3 of 3
- Sector Percentile
- 0.0%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
NL Healthcare
- Tracked Peers
- 3
- 4W Rank
- 3 of 3
- Avg 1W
- -2.4%
- Avg 4W
- -1.1%
- Trend Breadth
- 0.0%
- Positive MD
- 0.0%
NL Biotechnology
- Tracked Peers
- 2
- 4W Rank
- 2 of 2
- Avg 1W
- -3.8%
- Avg 4W
- -3.9%
- Trend Breadth
- 0.0%
- Positive RS
- 0.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.46
- 4W MD Change
- 48.1%
- Relative Strength
- -30.26
- 4W RS Change
- -42.3%
- Expectation
- Negative
- Probability
- 41.52%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 384.3K
- 13W Average
- 231.9K
- 52W Average
- 247.6K
- Vs 13W
- 1.7x
- Vs 52W
- 1.6x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 2.8%
- 52W Volatility
- 3.7%
- Upside Weeks
- 18
- Downside Weeks
- 33
- Downside Breadth
- 63.5%
- Avg Gain / Loss
- 2.8% / -2.5%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- AMS
- Country
- NL
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- EUR
- Market Cap
- 36.7M
Opportunity signals
- Volume is elevated versus the 13-week average, confirming attention.
- Latest weekly return ranks in the strongest part of its sector group.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 1.15 EUR | -7.3% | 1.40 EUR | 3.62 EUR | -0.46 | -30.26 | 384.3K | Off |
| 5 Jun 2026 | 1.24 EUR | -1.6% | 1.41 EUR | 3.70 EUR | -0.48 | -22.61 | 539.7K | Off |
| 29 May 2026 | 1.26 EUR | 1.2% | 1.42 EUR | 3.78 EUR | -0.59 | -21.53 | 336.8K | Off |
| 22 May 2026 | 1.25 EUR | -0.8% | 1.44 EUR | 3.87 EUR | -0.82 | -23.82 | 140.2K | Off |
| 15 May 2026 | 1.25 EUR | -2.0% | 1.45 EUR | 3.95 EUR | -0.89 | -21.26 | 122.4K | Off |
| 8 May 2026 | 1.28 EUR | -1.9% | 1.46 EUR | 4.04 EUR | -0.96 | -20.84 | 223.7K | Off |
| 1 May 2026 | 1.30 EUR | 1.6% | 1.48 EUR | 4.14 EUR | -1.07 | -19.69 | 227.8K | Off |
| 24 Apr 2026 | 1.28 EUR | -4.5% | 1.49 EUR | 4.25 EUR | -1.18 | -22.08 | 320.5K | Off |
| 17 Apr 2026 | 1.34 EUR | 1.9% | 1.50 EUR | 4.33 EUR | -1.22 | -19.43 | 117.9K | Off |
| 10 Apr 2026 | 1.32 EUR | -0.8% | 1.51 EUR | 4.41 EUR | -1.22 | -20.57 | 102.7K | Off |
| 3 Apr 2026 | 1.33 EUR | 1.5% | 1.52 EUR | 4.49 EUR | -1.23 | -17.96 | 88.6K | Off |
| 27 Mar 2026 | 1.31 EUR | 1.6% | 1.53 EUR | 4.58 EUR | -1.22 | -18.56 | 194.9K | Off |
| 20 Mar 2026 | 1.29 EUR | -4.7% | 1.54 EUR | 4.67 EUR | -1.05 | -20.60 | 214.7K | Off |
| 13 Mar 2026 | 1.35 EUR | -1.0% | 1.55 EUR | 4.74 EUR | -1.08 | -20.71 | 186.7K | Off |